Cargando…

Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease

Parkinson’s disease is the second largest neurodegenerative disease worldwide and is caused by a combination of genetics and environment. It is characterized by the death of neurons in the substantia nigra of the brain but is not solely a disease of the brain, as it affects multiple tissues and orga...

Descripción completa

Detalles Bibliográficos
Autores principales: Annesley, Sarah Jane, Allan, Claire Yvonne, Sanislav, Oana, Evans, Andrew, Fisher, Paul Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230639/
https://www.ncbi.nlm.nih.gov/pubmed/35736800
http://dx.doi.org/10.3390/proteomes10020020
_version_ 1784735114779951104
author Annesley, Sarah Jane
Allan, Claire Yvonne
Sanislav, Oana
Evans, Andrew
Fisher, Paul Robert
author_facet Annesley, Sarah Jane
Allan, Claire Yvonne
Sanislav, Oana
Evans, Andrew
Fisher, Paul Robert
author_sort Annesley, Sarah Jane
collection PubMed
description Parkinson’s disease is the second largest neurodegenerative disease worldwide and is caused by a combination of genetics and environment. It is characterized by the death of neurons in the substantia nigra of the brain but is not solely a disease of the brain, as it affects multiple tissues and organs. Studying Parkinson’s disease in accessible tissues such as skin and blood has increased our understanding of the disease’s pathogenesis. Here, we used lymphoblast cell lines generated from Parkinson’s disease patient and healthy age- and sex-matched control groups and obtained their whole-cell transcriptomes and proteomes. Our analysis revealed, in both the transcriptomes and the proteomes of PD cells, a global downregulation of genes involved in protein synthesis, as well as the upregulation of immune processes and sphingolipid metabolism. In contrast, we discovered an uncoupling of mRNA and protein expression in processes associated with mitochondrial respiration in the form of a general downregulation in associated transcripts and an upregulation in proteins. Complex V was different to the other oxidative phosphorylation complexes in that the levels of its associated transcripts were also lower, but the levels of their encoded polypeptides were not elevated. This may suggest that further layers of regulation specific to Complex V are in play.
format Online
Article
Text
id pubmed-9230639
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92306392022-06-25 Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease Annesley, Sarah Jane Allan, Claire Yvonne Sanislav, Oana Evans, Andrew Fisher, Paul Robert Proteomes Article Parkinson’s disease is the second largest neurodegenerative disease worldwide and is caused by a combination of genetics and environment. It is characterized by the death of neurons in the substantia nigra of the brain but is not solely a disease of the brain, as it affects multiple tissues and organs. Studying Parkinson’s disease in accessible tissues such as skin and blood has increased our understanding of the disease’s pathogenesis. Here, we used lymphoblast cell lines generated from Parkinson’s disease patient and healthy age- and sex-matched control groups and obtained their whole-cell transcriptomes and proteomes. Our analysis revealed, in both the transcriptomes and the proteomes of PD cells, a global downregulation of genes involved in protein synthesis, as well as the upregulation of immune processes and sphingolipid metabolism. In contrast, we discovered an uncoupling of mRNA and protein expression in processes associated with mitochondrial respiration in the form of a general downregulation in associated transcripts and an upregulation in proteins. Complex V was different to the other oxidative phosphorylation complexes in that the levels of its associated transcripts were also lower, but the levels of their encoded polypeptides were not elevated. This may suggest that further layers of regulation specific to Complex V are in play. MDPI 2022-06-01 /pmc/articles/PMC9230639/ /pubmed/35736800 http://dx.doi.org/10.3390/proteomes10020020 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Annesley, Sarah Jane
Allan, Claire Yvonne
Sanislav, Oana
Evans, Andrew
Fisher, Paul Robert
Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease
title Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease
title_full Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease
title_fullStr Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease
title_full_unstemmed Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease
title_short Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease
title_sort dysregulated gene expression in lymphoblasts from parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230639/
https://www.ncbi.nlm.nih.gov/pubmed/35736800
http://dx.doi.org/10.3390/proteomes10020020
work_keys_str_mv AT annesleysarahjane dysregulatedgeneexpressioninlymphoblastsfromparkinsonsdisease
AT allanclaireyvonne dysregulatedgeneexpressioninlymphoblastsfromparkinsonsdisease
AT sanislavoana dysregulatedgeneexpressioninlymphoblastsfromparkinsonsdisease
AT evansandrew dysregulatedgeneexpressioninlymphoblastsfromparkinsonsdisease
AT fisherpaulrobert dysregulatedgeneexpressioninlymphoblastsfromparkinsonsdisease